Sesha Sarojini Medical Infra Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
as on 28-06-2024
- Revenue 40.63%
(FY 2022)
- Profit -78.43%
(FY 2022)
- Ebitda -89.86%
(FY 2022)
- Net Worth 1.17%
(FY 2022)
- Total Assets 45.88%
(FY 2022)
About Sesha Sarojini Medical Infra
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 M.
Kavitha Kancherla and Ramadhara Kancharla serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PTC079267
- Company No.
079267
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sesha Sarojini Medical Infra?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kavitha Kancherla  | Director | 25-Mar-2013 | Current |
| Ramadhara Kancharla | Director | 21-Feb-2012 | Current |
Financial Performance and Corporate Structure Insights of Sesha Sarojini Medical Infra.
Sesha Sarojini Medical Infra Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.63% increase. The company also saw a substantial fall in profitability, with a 78.43% decrease in profit. The company's net worth moved up by a moderate rise of 1.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sesha Sarojini Medical Infra?
In 2020, Sesha Sarojini Medical Infra had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sesar Projects Private LimitedActive 12 years 6 monthsKavitha Kancherla and Ramadhara Kancharla are mutual person
- Hygieia Global Health Services Private LimitedActive 10 years 1 month
Ramadhara Kancharla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2020 | ₹1.10 M | Open |
How Many Employees Work at Sesha Sarojini Medical Infra?
Unlock and access historical data on people associated with Sesha Sarojini Medical Infra, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sesha Sarojini Medical Infra, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sesha Sarojini Medical Infra's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
